| A | B | D | E | F | G | H | I | J | |
|---|---|---|---|---|---|---|---|---|---|
1 | Timestamp | Name | Colorado Board of Pharmacy - Written Comments | ||||||
2 | 7/21/2025 9:35:51 | Virginia Rose Wolfe and surname is grant kinnean | I just found out my surname who do I report that too grant kinnean | ||||||
3 | 7/29/2025 | Brandy Flores, Pfizer Inc. | Pfizer Inc. values the opportunity to provide comments to the Board regarding proposed rule revisions governing licensure application and reporting timelines for Wholesaler entities during a Change of Ownership in 3 CCR 719-1- 15.01.14b. The suggested revisions to this rule would improve our ability to provide the Board with a timely, complete, and accurate application following a Change of Ownership and thus compliantly maintain patient supply of medicines in Colorado. Changes of Ownership such as acquisitions often require multiple approvals by regulating entities at federal and international levels. The existing application submission and notification timelines that occur prior to and on an ownership change date, respectively, can present a unique challenge during acquisitions wherein approvals are typically not final or known far enough in advance to provide complete and accurate information. Additionally, certain confidential information about the company subject to an acquisition that is required for an application is often not accessible to the acquiring company until after the change has occurred. Pfizer Inc. strongly believes that the Board’s proposed revisions to these timelines are practical and reasonable in terms of chronology and duration to submit required materials and notify the Board once an acquisition has closed. The proposed revision to 3 CCR 719-1-15.01.14b would also align the Wholesalers application timeline following a Change of Ownership to the Board’s application timeline required for a change in name or location (3 CCR 719-1- 15.01.14a) and the application timeline following a Transfer of Ownership for other licensed entities (3 CCR 719-1- 5.00.40). The proposed rulemaking would create consistency in application and reporting timelines that can support efforts to maintain compliant and complete licensure across designations. Pfizer Inc. appreciates the Board's efforts to ensure patient safety and maintain the integrity of the Colorado pharmaceutical supply chain and recognizes the Board’s interest in being made aware of Wholesalers’ Changes of Ownership in a timely manner. As a leading pharmaceutical manufacturer, we are committed to full compliance with all applicable laws and regulations and prioritize our responsibility to patients. | ||||||
4 | 9/16/2025 | Jennifer Falkenrath Director of Regulatory & Legislative Tracking LighthouseAI | Re: Public Comment on Proposed Rule – Reporting Change of Ownership for Wholesalers To Whom it May Concern: Thank you for the opportunity to provide comments on the proposed rule concerning the reporting of a change of ownership for wholesalers. The recommended revision—requiring submission of an application within 30 days after a change of ownership—offers a more practical and achievable timeframe. Ownership transitions often involve multiple layers of approval and present unique challenges during acquisitions, where final determinations are frequently unavailable early enough to supply complete and accurate information. Additionally, a company’s confidential acquisition details typically cannot be shared before the change occurs, making the current advance-notice requirement difficult to meet. Similarly, the proposed requirement to notify the Board within five (5) business days of a change of ownership provides necessary flexibility. This allowance accommodates weekends and unforeseen delays, enabling licensees to remain compliant while ensuring the Board receives accurate and timely information. Thank you for considering these comments in your rulemaking process. | ||||||
5 | |||||||||
6 | |||||||||
7 | |||||||||
8 | |||||||||
9 | |||||||||
10 | |||||||||
11 | |||||||||
12 | |||||||||
13 | |||||||||
14 | |||||||||
15 | |||||||||
16 | |||||||||
17 | |||||||||
18 | |||||||||
19 | |||||||||
20 | |||||||||
21 | |||||||||
22 | |||||||||
23 | |||||||||
24 | |||||||||
25 | |||||||||
26 | |||||||||
27 | |||||||||
28 | |||||||||
29 | |||||||||
30 | |||||||||
31 | |||||||||
32 | |||||||||
33 | |||||||||
34 | |||||||||
35 | |||||||||
36 | |||||||||
37 | |||||||||
38 | |||||||||
39 | |||||||||
40 | |||||||||
41 | |||||||||
42 | |||||||||
43 | |||||||||
44 | |||||||||
45 | |||||||||
46 | |||||||||
47 | |||||||||
48 | |||||||||
49 | |||||||||
50 | |||||||||
51 | |||||||||
52 | |||||||||
53 | |||||||||
54 | |||||||||
55 | |||||||||
56 | |||||||||
57 | |||||||||
58 | |||||||||
59 | |||||||||
60 | |||||||||
61 | |||||||||
62 | |||||||||
63 | |||||||||
64 | |||||||||
65 | |||||||||
66 | |||||||||
67 | |||||||||
68 | |||||||||
69 | |||||||||
70 | |||||||||
71 | |||||||||
72 | |||||||||
73 | |||||||||
74 | |||||||||
75 | |||||||||
76 | |||||||||
77 | |||||||||
78 | |||||||||
79 | |||||||||
80 | |||||||||
81 | |||||||||
82 | |||||||||
83 | |||||||||
84 | |||||||||
85 | |||||||||
86 | |||||||||
87 | |||||||||
88 | |||||||||
89 | |||||||||
90 | |||||||||
91 | |||||||||
92 | |||||||||
93 | |||||||||
94 | |||||||||
95 | |||||||||
96 | |||||||||
97 | |||||||||
98 | |||||||||
99 | |||||||||
100 |